Vertex Pharma (VRTX) Tops Q4 EPS by 50c, Revenues Beat; Offers FY20 Revenue Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq futures sink as AI doubts resurface, oil jumps
- Oil jumps on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 524.52 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $524.52 | 52 Week High | $134.71 | |||
| Open | $524.52 | 52 Week Low | $73.31 | |||
| Day High | $524.52 | P/E | N/A | |||
| Day Low | $524.52 | EPS | $-1.98 | |||
| Volume | 64,403 | |||||
